Skip to main content

About your Search

Search Results 0 to 1 of about 2
of money to develop them. but then again, we all have this problem with keeping health care costs down and obama care wants generic competition for biologics. what's the right road to take there? >> you know, joe, we've been in this industry for over 135 years. for us, we've taken a focus and we pursue both small molecule as well as bioological routes to address some of the most oppressing diseases out there. if you take alzheimer's, we have the biologic but we have a base inhibitor in phase two -- >> would you pay a lobbyist, would you get lobbyists for eli lilly to try to make it that you don't have to have generic competition for biologics, is that something eli lilly would do, or do you go along with it? >> well, remember, in the affordable care act we did get an extension in terms of data protection, as we should be, to at least 12 years. we believe that's very important for us to have a reasonable period to generate return on investment that we make in r&d. we still are the industry that invests the most in r&d, research and development, in this country. we from a policy standpoi
. obama had two rebates that didn't work. people know it's not permanent and pay down their credit cards but doesn't affect spending. got to go. hang on. when we come back you can whack at me. we got two major earnings reports out after today's close bell. we begin with microsoft, john joins us with the details. >> reporter: microsoft turned in solid results. revenue just a little bit short of expectations at 21.46 billion dollars. eps a penny better at 76 cents. microsoft says when you count deferred revenue thing are actually a little bit better than that. a couple of highlights. windows, the windows group did better than expected at 5.8 billion in revenue. the business division did a little shy at 5.7. now jane wells has a little bit on starbucks, another big company. jane? >> reporter: john, shares have been up after hours. they were up over 3% at one point. starbucks reported its best holiday ever, best earnings per share ever at 57 cents. improving operator margins to 16.6%. stronger comp sales in the u.s. and china and the company says the turn around in europe is under way. but t
Search Results 0 to 1 of about 2